{
    "clinical_study": {
        "@rank": "13252", 
        "arm_group": {
            "arm_group_label": "insulin pre-treatment", 
            "arm_group_type": "Experimental", 
            "description": "insulin pre-treatment of pregnant diabetic patients who receive betamethasone"
        }, 
        "brief_summary": {
            "textblock": "Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on\n      weight, given to pregnant patients with gestational or preexisting diabetes receiving\n      betamethasone can provide adequate glycemic control.\n\n      Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help\n      maintain euglycemia for pregnant patients with gestational and preexisting diabetes after\n      steroid administration, and possibly impact length of hospital admission."
        }, 
        "brief_title": "Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperglycemia in Pregnant Diabetic Patients", 
        "condition_browse": {
            "mesh_term": "Hyperglycemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Pregnant women with gestational or pre-existing diabetes admitted to the University\n             of Minnesota\n\n          2. Must be 18 years or older\n\n          3. Must speak English, Spanish, or Somali\n\n          4. Patients must receive steroids for fetal lung maturity as part of their hospital\n             course\n\n        Exclusion Criteria:\n\n          1. Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ\n             disease\n\n          2. Pregnant women who need to be emergently delivered due to maternal or fetal\n             complications of pregnancy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875107", 
            "org_study_id": "1301M26861"
        }, 
        "intervention": {
            "arm_group_label": "insulin pre-treatment", 
            "description": "insulin pre-treatment of pregnant diabetic patients who receive betamethasone", 
            "intervention_name": "insulin pre-treatment", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 6, 2013", 
        "location": {
            "contact": {
                "email": "tienx015@umn.edu", 
                "last_name": "Shelly Tien, M.D.", 
                "phone": "617-894-2978"
            }, 
            "facility": {
                "address": {
                    "city": "Minneapolis", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55454"
                }, 
                "name": "University of Minnesota Medical Center"
            }, 
            "investigator": {
                "last_name": "Shelly H Tien, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients", 
        "overall_official": {
            "affiliation": "University of Minnesota - Clinical and Translational Science Institute", 
            "last_name": "Shelly H Tien, , M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pregnant diabetic patients admitted to the hospital who receive steroids for fetal lung maturity will have their blood glucose levels checked before and after receiving steroids.  Blood glucose levels will be checked fasting and postprandial until the levels are consistently less than 160.  This will vary for patients, but will be on average 2 to 14 days.", 
            "measure": "Number of hospital days until euglycemia in pregnant diabetic patients receiving steroids who are pre-treated with insulin.", 
            "safety_issue": "No", 
            "time_frame": "number of hospital days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875107"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Minnesota - Clinical and Translational Science Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Minnesota - Clinical and Translational Science Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}